IMPERAGEN LIMITED
Company number 13761050 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£4,699,913
Balance sheet as at 2025-12-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2021-11-23
- Employees
- 14 (2025 accounts · was 12 in 2024)
- Registered office
- Unit 11, Williams House Lloyd Street North, Manchester Science Park, Manchester, England, M15 6SE
- Postcode
- M15 6SE
- Capital
- 22 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2025-12-31
- Next due by
- 2027-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2025-12-06
- Next due by
- 2026-12-20
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 7 current · 5 resigned
Guy LEVY-YURISTA
Director
James William GIBBONS
Director
Robert WILSON
Director
Peter SEUFER-WASSERTHAL
Director
IQ CAPITAL DIRECTORS NOMINEES LTD
Corporate Director
Contact details
- Website
- imperagen.com
At Imperagen, we are reinventing enzyme engineering from the ground up with a truly innovative platform - Imperagen = Digital Enzyme Evolution™
Among its peers
Top 10%
by shareholders' funds, of 47 similar companies in M
Among the biggest employers among its local peers (14 staff).
Trading since 2021.
No.4 of the largest research and experimental development on biotechnology companies in Manchester →
Competitors Manchester
This company ranks 4 among research and experimental development on biotechnology in Manchester.